Cargando…
Anti-Pathogenic Properties of the Combination of a T3SS Inhibitory Halogenated Pyrrolidone with C-30 Furanone
Antimicrobial resistance is one of the current public health challenges to be solved. The World Health Organization (WHO) has urgently called for the development of strategies to expand the increasingly limited antimicrobial arsenal. The development of anti-virulence therapies is a viable option to...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707098/ https://www.ncbi.nlm.nih.gov/pubmed/34946717 http://dx.doi.org/10.3390/molecules26247635 |
_version_ | 1784622353853972480 |
---|---|
author | Aburto-Rodríguez, Nelly Araceli Muñoz-Cázares, Naybi Castro-Torres, Víctor Alberto González-Pedrajo, Bertha Díaz-Guerrero, Miguel García-Contreras, Rodolfo Quezada, Héctor Castillo-Juárez, Israel Martínez-Vázquez, Mariano |
author_facet | Aburto-Rodríguez, Nelly Araceli Muñoz-Cázares, Naybi Castro-Torres, Víctor Alberto González-Pedrajo, Bertha Díaz-Guerrero, Miguel García-Contreras, Rodolfo Quezada, Héctor Castillo-Juárez, Israel Martínez-Vázquez, Mariano |
author_sort | Aburto-Rodríguez, Nelly Araceli |
collection | PubMed |
description | Antimicrobial resistance is one of the current public health challenges to be solved. The World Health Organization (WHO) has urgently called for the development of strategies to expand the increasingly limited antimicrobial arsenal. The development of anti-virulence therapies is a viable option to counteract bacterial infections with the possibility of reducing the generation of resistance. Here we report on the chemical structures of pyrrolidones DEXT 1–4 (previously identified as furan derivatives) and their anti-virulence activity on Pseudomonas aeruginosa strains. DEXT 1–4 were shown to inhibit biofilm formation, swarming motility, and secretion of ExoU and ExoT effector proteins. Also, the anti-pathogenic property of DEXT-3 alone or in combination with furanone C-30 (quorum sensing inhibitor) or MBX-1641 (type III secretion system inhibitor) was analyzed in a model of necrosis induced by P. aeruginosa PA14. All treatments reduced necrosis; however, only the combination of C-30 50 µM with DEXT-3 100 µM showed significant inhibition of bacterial growth in the inoculation area and systemic dispersion. In conclusion, pyrrolidones DEXT 1–4 are chemical structures capable of reducing the pathogenicity of P. aeruginosa and with the potential for the development of anti-virulence combination therapies. |
format | Online Article Text |
id | pubmed-8707098 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87070982021-12-25 Anti-Pathogenic Properties of the Combination of a T3SS Inhibitory Halogenated Pyrrolidone with C-30 Furanone Aburto-Rodríguez, Nelly Araceli Muñoz-Cázares, Naybi Castro-Torres, Víctor Alberto González-Pedrajo, Bertha Díaz-Guerrero, Miguel García-Contreras, Rodolfo Quezada, Héctor Castillo-Juárez, Israel Martínez-Vázquez, Mariano Molecules Article Antimicrobial resistance is one of the current public health challenges to be solved. The World Health Organization (WHO) has urgently called for the development of strategies to expand the increasingly limited antimicrobial arsenal. The development of anti-virulence therapies is a viable option to counteract bacterial infections with the possibility of reducing the generation of resistance. Here we report on the chemical structures of pyrrolidones DEXT 1–4 (previously identified as furan derivatives) and their anti-virulence activity on Pseudomonas aeruginosa strains. DEXT 1–4 were shown to inhibit biofilm formation, swarming motility, and secretion of ExoU and ExoT effector proteins. Also, the anti-pathogenic property of DEXT-3 alone or in combination with furanone C-30 (quorum sensing inhibitor) or MBX-1641 (type III secretion system inhibitor) was analyzed in a model of necrosis induced by P. aeruginosa PA14. All treatments reduced necrosis; however, only the combination of C-30 50 µM with DEXT-3 100 µM showed significant inhibition of bacterial growth in the inoculation area and systemic dispersion. In conclusion, pyrrolidones DEXT 1–4 are chemical structures capable of reducing the pathogenicity of P. aeruginosa and with the potential for the development of anti-virulence combination therapies. MDPI 2021-12-16 /pmc/articles/PMC8707098/ /pubmed/34946717 http://dx.doi.org/10.3390/molecules26247635 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Aburto-Rodríguez, Nelly Araceli Muñoz-Cázares, Naybi Castro-Torres, Víctor Alberto González-Pedrajo, Bertha Díaz-Guerrero, Miguel García-Contreras, Rodolfo Quezada, Héctor Castillo-Juárez, Israel Martínez-Vázquez, Mariano Anti-Pathogenic Properties of the Combination of a T3SS Inhibitory Halogenated Pyrrolidone with C-30 Furanone |
title | Anti-Pathogenic Properties of the Combination of a T3SS Inhibitory Halogenated Pyrrolidone with C-30 Furanone |
title_full | Anti-Pathogenic Properties of the Combination of a T3SS Inhibitory Halogenated Pyrrolidone with C-30 Furanone |
title_fullStr | Anti-Pathogenic Properties of the Combination of a T3SS Inhibitory Halogenated Pyrrolidone with C-30 Furanone |
title_full_unstemmed | Anti-Pathogenic Properties of the Combination of a T3SS Inhibitory Halogenated Pyrrolidone with C-30 Furanone |
title_short | Anti-Pathogenic Properties of the Combination of a T3SS Inhibitory Halogenated Pyrrolidone with C-30 Furanone |
title_sort | anti-pathogenic properties of the combination of a t3ss inhibitory halogenated pyrrolidone with c-30 furanone |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707098/ https://www.ncbi.nlm.nih.gov/pubmed/34946717 http://dx.doi.org/10.3390/molecules26247635 |
work_keys_str_mv | AT aburtorodrigueznellyaraceli antipathogenicpropertiesofthecombinationofat3ssinhibitoryhalogenatedpyrrolidonewithc30furanone AT munozcazaresnaybi antipathogenicpropertiesofthecombinationofat3ssinhibitoryhalogenatedpyrrolidonewithc30furanone AT castrotorresvictoralberto antipathogenicpropertiesofthecombinationofat3ssinhibitoryhalogenatedpyrrolidonewithc30furanone AT gonzalezpedrajobertha antipathogenicpropertiesofthecombinationofat3ssinhibitoryhalogenatedpyrrolidonewithc30furanone AT diazguerreromiguel antipathogenicpropertiesofthecombinationofat3ssinhibitoryhalogenatedpyrrolidonewithc30furanone AT garciacontrerasrodolfo antipathogenicpropertiesofthecombinationofat3ssinhibitoryhalogenatedpyrrolidonewithc30furanone AT quezadahector antipathogenicpropertiesofthecombinationofat3ssinhibitoryhalogenatedpyrrolidonewithc30furanone AT castillojuarezisrael antipathogenicpropertiesofthecombinationofat3ssinhibitoryhalogenatedpyrrolidonewithc30furanone AT martinezvazquezmariano antipathogenicpropertiesofthecombinationofat3ssinhibitoryhalogenatedpyrrolidonewithc30furanone |